Wang, Dong
Xu, Jiahui
Liu, Bingjie
He, Xueyan
Zhou, Lei
Hu, Xin
Qiao, Feng
Zhang, Anli
Xu, Xiaojun
Zhang, Huafeng
Wicha, Max S
Zhang, Lixing
Shao, Zhi-ming
Liu, Suling
Article History
Received: 2 May 2017
Revised: 23 August 2017
Accepted: 29 August 2017
First Online: 13 October 2017
Competing interests
: MSW has financial holdings and is a scientific advisor for OncoMed Pharmaceuticals, is a scientific advisor for Verastem, Paganini and MedImmune and receives research support from Dompe Pharmaceuticals and MedImmune. The remaining authors declare no conflict of interest.